Literature DB >> 16325624

Functional bowel and anorectal disorders in patients with pelvic organ prolapse and incontinence.

John E Jelovsek1, Matthew D Barber, Marie Fidela R Paraiso, Mark D Walters.   

Abstract

OBJECTIVE: The purpose of this study was 1) to determine the prevalence of functional bowel and anorectal disorders as defined by the Rome II criteria in patients with advanced pelvic organ prolapse (POP) and urinary incontinence (UI), and (2) to determine if the extent of prolapse on gynecologic examination is related to the subtypes of constipation or any functional anorectal pain disorder. STUDY
DESIGN: Three hundred and two consecutive female subjects presenting to a tertiary urogynecology clinic were enrolled. Demographic, general medical, and physical examination information, including POPQ measurements and a standardized sacral neurologic evaluation, were collected. The prevalence of functional disorders of the bowel, rectum, and anus as defined by the Rome II criteria were collected using the Rome II Modular questionnaire. Relationships of functional disorders to various components of the vaginal examination were reviewed.
RESULTS: Thirty-six percent (108/302) met the criteria for constipation, including the following subtypes: 19% outlet constipation, 5% functional constipation, 5% constipation predominant irritable bowel syndrome (IBS), and 7% IBS-outlet. Nineteen percent (56/302) of subjects had IBS or 1 of its subtypes. Functional diarrhea was seen in 6% (17/302), fecal incontinence in 19% (58/302), and anorectal pain disorders in 25% (77/302). After controlling for age, parity, diabetes, constipating medications, and previous pelvic surgery, there were no differences in the prevalence of constipation or any of its subtypes between patients with UI and those with stage 3 or 4 POP. Fecal incontinence was independently associated with UI (adjusted odds ratio [OR] 6.3; 95% CI 2.6-19.1), but not advanced POP. Neither overall stage of POP nor stage of posterior vaginal prolapse was significantly associated with any of the functional bowel disorders, including constipation and its subtypes. Perineal body measurement was significantly longer in patients with outlet type constipation (mean 3.5 +/- 0.6 cm vs 3.1 +/- 0.9 cm, P < .01) and in those with proctalgia fugax (mean 3.4 +/- 1.0 vs 3.1 +/- 0.8, P < .05).
CONCLUSION: There is a high prevalence of constipation and anorectal pain disorders in women with urinary incontinence and pelvic organ prolapse. However, patients with stage 3 or 4 pelvic organ prolapse have similar rates of constipation compared with those with urinary incontinence. Constipation and its subtypes are not related to the stage of pelvic organ prolapse. It appears that either constipation is not a significant contributor to prolapse, or constipation contributes equally to the development of both urinary incontinence and pelvic organ prolapse.

Entities:  

Mesh:

Year:  2005        PMID: 16325624     DOI: 10.1016/j.ajog.2005.07.016

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  30 in total

1.  The Impact of Obesity and Weight Loss on Urinary and Bowel Incontinence Symptoms in Women.

Authors:  Alicia C Ballard; Holly E Richter
Journal:  Menopausal Med       Date:  2011-08-01

Review 2.  Posterior vaginal compartment prolapse and defecatory dysfunction: are they related?

Authors:  Cara L Grimes; Emily S Lukacz
Journal:  Int Urogynecol J       Date:  2012-01-06       Impact factor: 2.894

3.  Controlling anal incontinence in women by performing anal exercises with biofeedback or loperamide (CAPABLe) trial: Design and methods.

Authors:  J Eric Jelovsek; Alayne D Markland; William E Whitehead; Matthew D Barber; Diane K Newman; Rebecca G Rogers; Keisha Dyer; Anthony Visco; Vivian W Sung; Gary Sutkin; Susan F Meikle; Marie G Gantz
Journal:  Contemp Clin Trials       Date:  2015-08-18       Impact factor: 2.226

Review 4.  Posterior compartment defect repair in vaginal surgery: update on surgical techniques.

Authors:  Van Anh T Ginger; Kathleen C Kobashi
Journal:  Curr Urol Rep       Date:  2007-09       Impact factor: 3.092

5.  Prevalence of unreported bowel symptoms in women with pelvic floor dysfunction and the impact on their quality of life.

Authors:  Leonardo Robson Pinheiro Sobreira Bezerra; José Ananias Vasconcelos Neto; Camila Teixeira Moreira Vasconcelos; Sara Arcanjo Lino Karbage; Amene Cidrão Lima; Isabella Parente Ribeiro Frota; Adriana Bombonato de Oliveira Rocha; Sandra Rebouças Macedo; Cassia Fernandes Coelho; Marília Karla Nunes Costa; Geisele Cavalcante de Souza; Sthela Murad Regadas; Kathiane Lustosa Augusto
Journal:  Int Urogynecol J       Date:  2014-02-22       Impact factor: 2.894

6.  Constipation symptoms before and after vaginal and abdominal pelvic reconstructive surgery.

Authors:  Minita Patel; David M O'Sullivan; Christine A LaSala
Journal:  Int Urogynecol J       Date:  2011-07-06       Impact factor: 2.894

7.  Outcome measures to assess anatomy and function of the posterior vaginal compartment.

Authors:  C L Grimes; J Tan-Kim; C W Nager; K Y Dyer; S A Menefee; G B Diwadkar; R H Overholser; R Xu; E S Lukacz
Journal:  Int Urogynecol J       Date:  2014-01-29       Impact factor: 2.894

8.  International Urogynecology Consultation Chapter 1 Committee 5: relationship of pelvic organ prolapse to associated pelvic floor dysfunction symptoms: lower urinary tract, bowel, sexual dysfunction and abdominopelvic pain.

Authors:  Marie-Andrée Harvey; Hui Ju Chih; Roxana Geoffrion; Baharak Amir; Alka Bhide; Pawel Miotla; Peter F W M Rosier; Ifeoma Offiah; Manidip Pal; Alexandriah Nicole Alas
Journal:  Int Urogynecol J       Date:  2021-08-02       Impact factor: 2.894

9.  Increased fluid intake is associated with bothersome bowel symptoms among women with urinary incontinence.

Authors:  Saya Segal; Emily K Saks; Tirsit S Asfaw; Lily A Arya
Journal:  Female Pelvic Med Reconstr Surg       Date:  2013 May-Jun       Impact factor: 2.091

10.  Obstructive defecation in middle-aged women.

Authors:  Madhulika G Varma; Stacey L Hart; Jeanette S Brown; Jennifer M Creasman; Stephen K Van Den Eeden; David H Thom
Journal:  Dig Dis Sci       Date:  2008-03-14       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.